| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
CAMP combination
2
relevant articles (0 outcomes,
1 trials/studies)
found for this Bio-Agent
Description: chemotherapy protocol consisting of the above cpds; used in treatment of patients with doxorubicin-resistant intermediate- & hight-grade malignant non-Hodgkin's lymphoma
Bio-Agent Context: Research Results
Related Diseases
| 1. | Non-Hodgkin Lymphoma (Lymphosarcoma)
12/01/1990
- "Phase II study of lomustine, cytarabine, mitoxantrone, and prednisone (CAMP) combination chemotherapy for doxorubicin-resistant intermediate- and high-grade malignant non-Hodgkin's lymphoma."
Order ALL the reference details at left... |
| 2. | Bronchogenic Carcinoma
01/01/1979
- ""CAMP" combination chemotherapy for unresectable non-oat cell bronchogenic carcinoma."
Order ALL the reference details at left... |
Related Drugs and Biologics
| 1. | Prednisone (Sone)
|
| 2. | Mitoxantrone (Novantrone)
|
| 3. | Lomustine (CCNU)
|
| 4. | Doxorubicin (Adriamycin)
|
| 5. | Cytarabine (Cytosar-U)
|
Related Therapies and Procedures
| 1. | Drug Therapy (Chemotherapy)
|
Best Treatments:
Research Summary Report
on Non-Hodgkin Lymphoma
Research Summary Report
on Non-Hodgkin Lymphoma
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
CureHunter research summary reports will vary in length from 25 to 250 pages.
Analytic charts allow you and your physicians to see at a glance your
medication options—including new, promising, off-label and experimental
all rated for clinical efficacy.
- Free Updates for 1 Year
- All 766 Outcomes
- Top 200 Key Drugs and Biologics
- Top 50 Key Therapies and Procedures
- Detailed History Charts
- Full Research Reference Details
- Sample PDF Report on Psoriasis >>
| Price: | $24.00
& Delivery via
PDF download
updates for 1 year |
Research Interface
- Unlimited Disease, Drug and Therapy Search
- 2 clicks from Disease to Drug to Evidence
- Trial References
- All the Positive Outcomes
- Detailed Relationship Timeline Charts
- Full Article Reference Details
- Includes Mobile Interface Subscription
- One-click to FDA Products/Patents
- Request Institution License Details >>
| Price: | $490.00
access via web interface 1 year subscription |
Mobile Interface
- Access from any web enabled PDA or Phone
- Trial references
- All the Positive Outcomes
- Drug and Therapy searches
- Full Article Reference Details
- Try Mobile Interface >>
| Price: | $45.00
access via "curehunter.com/m" 1 year subscription |